A market leader in the GLP-1 space, Novo Nordisk markets its semaglutide drugs under brand names Ozempic (pre-filled pen) and Rybelsus (oral tablet) for type II diabetes (T2D), and Wegovy ...

Novo Nordisk NVO and Viking Therapeutics VKTX have emerged as notable players in the obesity space. A market leader in the ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

International study looked at 800 patients in 37 countries Patients getting the drug saw less inflammation and fat in their livers Lead researcher says it could help treat liver disease like MASH ...

It’s not specific to Ozempic. It can happen with any of the oh, so popular medications like Wegovy, Zepbound and Mounjuro that can cause rapid weight loss. The key things to remember is that GLP ...

In 2022, the FDA opened the door, allowing teens 12 years and older to be prescribed Semaglutide, it’s the active ingredient in Ozempic and Wegovy. Semaglutide dispense rate increased by 594% ...

Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Ozempic. Wegovy. Rybelsus. What do these medications have in common? They all contain the active ingredient semaglutide.

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. Researchers administered weekly injections — either a placebo or ...

The FDA directed compounding pharmacies and physicians to cease compounding Ozempic and Wegovy by April 22, and outsourcing facilities to stop producing and distributing the medications by May 22.